ABOUT

HOME   > ABOUT

ABOUT

Science Avizorex pharma
AVX Pharma is a clinical-stage Spanish biotech ophthalmology company founded in 2013 in Alicante and with offices in Barcelona Science Park, focused on developing novel therapies for Dry Eye Syndrome based on Prof. Carlos Belmonte research on the role of temperature-sensitive neurons in tear film regulation at the Alicante Neurosciences Institute. AVX Pharma lead product candidate AVX-012, a Small Molecule with a new Mechanism of Action, is in clinical development for Dry Eye Syndrome.